LIVE

BAK

Braskem S.A.

BAK

NYSE·Basic Materials·Chemicals·Mkt cap $936.4M

$2.45

▲ +4.26%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$2.25 - $5.40

P/E

—

Fwd P/E

-1.23

Beta

0.67

Div Yield

—

Avg Vol

2.6M

Shares Out

398.5M

Mkt Cap

$936.4M

Price action

Price chart

Down 29.9% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

▲

Bull Case

4 reasons

  • Vertically integrated production across the value chain from raw materials to finished polymers
  • Diversified geographic presence in Brazil, North America, Europe, and Mexico reducing regional risk
  • Green polymer technology and renewable resource capabilities for sustainable product differentiation
  • Cost-competitive Brazilian operations with access to affordable feedstock and energy
▼

Bear Case

1 risk

  • Low volatility (beta 0.7).

Growth

Strong growth ahead

Rising global demand for thermoplastics in packaging, automotive, and construction sectors

Value

Deep value opportunity - significant discount to Commodity Chemicals peers

Momentum

Falling

-34.9% over 3m

Quality

Weak

Weak fundamentals - proceed with caution

Dividend

None

No dividend

Earnings track record

Recent earnings results

AI-summarized recap of last quarter, plus the surprise on every print.

Next: May 12, 2026

“
Q2 26 RECAP

MAY 14, 2026

Reported EPS of $0.69 vs $0.21 consensus (+234.5% surprise). Revenue of $3.2B vs $3.4B expected (-7.1%).

EPS beat +234.5%
Revenue miss

EPS surprise · last 4Q

2 of 2 beats

Q2 26

+234.5%

Q2 26

+234.5%

Next: May 12, 2026

Revenue trend · last 8Q

—

—

—

+9%

-6%

-19%

-23%

-22%

Q2 24

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

$754.4M

$841.0M

$757.4M

$769.6M

$706.2M

$684.1M

$581.8M

$599.8M

Margins · last 8Q

Gross

—

Operating

—

Profit

9.3%

View full earnings history →

Wall Street consensus

1 analyst · 0% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

0%

Hold

0%

Sell

1

100%

Median Price Target

$1.50

▼ -38.8% vs $2.45

Low $1.50
Median $1.50
High $1.50

Latest: Citi · Jun 25, 2026

1 analyst covering

View full analyst page →

vs Industry

How BAK stacks vs Chemicals

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.